Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease

American Journal of Clinical Nutrition

Volumn 83, Issue 4, 2006, Pages 829-834

  Rutten, Erica P A ^a   Franssen, Frits M E ^a   Engelen, Marielle P K J ^a   Wouters, Emiel F M ^a   Deutz, Nicolaas E P ^a   Schols, Annemie M W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cachexia; Chronic obstructive pulmonary disease; Myofibrillar protein breakdown

Indexed keywords

3 METHYLHISTIDINE; AMINO ACID; PHENYLALANINE; TRACER; TYROSINE; DEUTERIUM; MUSCLE PROTEIN;

ARTICLE; BODY FAT; BODY MASS; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PROTEIN DEGRADATION; PROTEIN METABOLISM; SCANNING ELECTRON MICROSCOPY; SCHOOL CHILD; AGED; BLOOD; BODY COMPOSITION; CASE CONTROL STUDY; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; MUSCLE FIBRIL; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

AGED; AMINO ACIDS; BODY COMPOSITION; CACHEXIA; CASE-CONTROL STUDIES; DEUTERIUM; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOFIBRILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 33646681467     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/83.4.829     Document Type: Article

References (34)

1. Schols AMWJ, Soeters PB, Dingemans AMC, Mostert R, Frantzen PJ, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993;147:1151-6.
2. Engelen MPKJ, Schols AMWJ, Lamers RJS, Wouters EFM. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr 1999;18:275-80.
3. Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10:2807-13.
4. Gosker HR, Lencer NH, Franssen FM, van der Vusse GJ, Wouters EF, Schols AM. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003;123:1416-24.
5. Engelen MPKJ, Schols AMWJ, Does JD, Wouters EFM. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000;71:733-8.
6. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000;94:859-67.
7. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-9.
8. Tracey KJ. Lethal weight loss: the focus shifts to signal transduction. Sci STKE 2002;2002:PE21.
9. Morrison WL, Gibson JNA, Scrimgeour C, Rennie MJ. Muscle wasting in emphysema. Clin Sci 1988;75:415-20.
10. Broekhuizen R, Grimble RF, Howell WM, et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1β - 511 single nucleotide polymorphism. Am J Clin Nutr 2005;82:1059-64.
11. Hofford JM, Milakofsky L, Vogel WH, Sacher RS, Savage GJ, Pell S. The nutritional status in advanced emphysema associated with chronic bronchitis. A study of amino acid and catecholamine levels. Am Rev Respir Dis 1990;141:902-8.
12. Schols AMWJ, Deutz NEP, Mostert R, Wouters EFM. Plasma amino acid levels in patients with chronic obstructive pulmonary disease. Monaldi Arch. Chest Dis 1993;48:546-8.
13. Vissers YL, von Meyenfeldt MF, Braulio VB, Luiking YC, Deutz NE. Measuring whole-body actin/myosin protein breakdown in mice using a primed constant stable isotope-infusion protocol. Clin Sci (Lond) 2003;104:585-90.
14. Gross NJ. The GOLD standard for chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1047-8.
15. Picado C, Deulofeu R, Lleonart R, et al. Lipid and protein metabolism in asthma. Effects of diet and corticosteroid therapy. Allergy 1999;54:569-75.
16. Guhan AR, Cooper S, Oborne J, Lewis S, Bennett J, Tattersfield AE. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax 2000;55:650-6.
17. Clausen JL, Coates AL, Quanjer PH. Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop. Eur Respir J 1997;10:1205-6.
18. Abumrad NN, Rabin D, Diamond MP, Lacy WW. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism 1981;30:936-40.
19. Van Eijk HMH, Rooyakkers DR, Deutz NEP. Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 um Sperisorb ODS 2 column. J Chromatogr 1993;620:143-8.
20. Van Eijk HM, Rooyakkers DR, Soeters PB, Deutz NE. Determination of amino acid isotope enrichment using liquid chromatography-mass spectrometry. Anal Biochem 1999;271:8-17.
21. Engelen MPKJ, Deutz NEP, Wouters EFM, Schols AMWJ. Enhanced levels of whole body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:1488-92.
22. Steiner MC, Barton RL, Singh SJ, Morgan MD. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002;19:626-31.
23. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part I: review of principles and methods. Clin Nutr 2004;23:1226-43.
24. Deutz NE, Wagenmakers AJ, Soeters PB. Discrepancy between muscle and whole body protein turnover. Curr Opin Clin Nutr Metab Care 1999;2:29-32.
25. Ballard FJ, Tomas FM. 3-Methylhistidine as a measure of skeletal muscle protein breakdown in human subjects: the case for its continued use. Clin Sci (Lond) 1983;65:209-15.
26. Wei IW, McFadden ER Jr, Hoppel CL. Effect of theophylline on urinary excretion of 3-methylhistidine in patients with lung disease. Metabolism 1991;40:702-6.
27. Pouw EM, Schols AMWJ, Deutz NEP, Wouters EFM. Plasma and muscle amino-acid levels in relation to resting energy expenditure and inflammation in stable COPD. Am J Respir Crit Care Med 1998;158:797-801.
28. Yoneda T, Yoshikawa M, Fu A, Tsukaguchi K, Okamoto Y, Takenaka H. Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease. Nutrition 2001;17:95-9.
29. Hasselgren PO, Fischer JE. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 2001;233:9-17.
30. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 2005;37:1974-84.
31. Agusti A, Morla M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 2004;59:483-7.
32. Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J 2001;15:1169-80.
33. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1179-84.
34. Topp H, Unverzagt S, Rudloff S, Schoch G, Manz F, Fusch C. Diurnal variation in the renal excretion of modified RNA catabolites in humans. Clin Sci (Lond) 2003;105:195-202.